Regulatory Blog

US Food and Drug Administration (FDA) has finalized guidance for industry and agency staff on the use of Principles of Premarket Pathways...

On January 28, 2022 Swismedic released a list of guidances for different segments, check out the below important list of swiss medic...

Irelands HPRA released a few guidances in the past week Guide to New Applications and Variations to Manufacturer's Authorisations This...

This guidance is intended to assist applicants and holders of an abbreviated new drug application (ANDA) in updating their labeling...

US FDA issued two medical devices (final guidance documents on January 26, 2022, to help sponsors better incorporate and capture...

FDA published a series of guidances on January 26, 2022 focussing on Generic Drug Application Submissions, Labeling, and Review. These...

On January 20, 2022, the UK MHRA released guidance on how to complete your Electronic Application Form (eAF) and Cover Letter. This form...

China’s National Medical Products Administration (NMPA) released 2 guidelines supporting the development and registration of drug-device...

National Pharmaceutical Pricing Authority (NPPA) was established through a Government of India Resolution dated 29th August, 1997 as an...

This guidance document addresses a number of questions that users of the scientific advice or protocol assistance procedures may have and...

UK MHRA updated its guidance on How to apply for a clinical trial including eligibility, phases, model IMPDs, costs, and how to make...

SFDA updated their Biowaiver guideline recently. These guidelines are intended to facilitate and support the workflow of drug...

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating the UK medical devices market. This guide...